The company announced that it would provide no cost vaccinations for members who are students and employees at the campus.
In a statement, Horizon BCBSNJ said that the New Jersey Department of Health and Rutgers, with support from the Centers for Disease Control and Prevention, strongly recommend serogroup B meningococcal vaccine (MenB) for certain at-risk individuals at the New Brunswick location, including undergraduate and graduate students, employees and medical staff.
Horizon BCBSNJ said it would waive any claims, benefit limitations or medical policy restrictions for Meningitis B vaccine boosters that at-risk individuals with Horizon BCBSNJ coverage receive at the Rutgers University Student Health Centers, on-campus clinics, local health care providers and pharmacies.
“Meningitis B is a rare but dangerous disease that if not treated promptly, could have very serious health consequences,” said Dr. Thomas Graf, Horizon BCBSNJ vice president and chief medical officer.
“Horizon shares the urgency expressed by Rutgers University, the New Jersey departments of Health and Banking and Insurance and the medical community to respond swiftly to this outbreak and get our members properly vaccinated and protected from Meningitis B,” Graf said.